102 related articles for article (PubMed ID: 34080945)
1. The TIM-3 Rs10053538 Polymorphism Is Associated with Clinical Prognosis of Colorectal Cancer.
Liu Y; Duan Y; Yang N; Li B; Kong D
Immunol Invest; 2022 Jul; 51(5):1302-1312. PubMed ID: 34080945
[TBL] [Abstract][Full Text] [Related]
2. TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.
Cui SJ; Li Y; Zhou RM; Liu L; Cao SR; Huang X; Huo XR; Wang N
Environ Mol Mutagen; 2021 Apr; 62(4):273-283. PubMed ID: 33723872
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.
Wang Z; Liu X; Wang X; Chong T; Lin S; Wang M; Ma X; Liu K; Xu P; Feng Y; Dai Z
Oncotarget; 2016 Jul; 7(28):43703-43712. PubMed ID: 27248321
[TBL] [Abstract][Full Text] [Related]
5. TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis.
Mewes C; Alexander T; Büttner B; Hinz J; Alpert A; Popov AF; Ghadimi M; Beißbarth T; Tzvetkov M; Grade M; Quintel M; Bergmann I; Mansur A
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171904
[No Abstract] [Full Text] [Related]
6. [Association of Crohn's disease with T cell immunoglobulin and mucin domain 3 gene polymorphisms in Chinese patients].
Sun L; Wu H; Cao SG; Xia XP; Lin XQ; Jin J; Ding R; Jiang Y
Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):667-672. PubMed ID: 28870035
[No Abstract] [Full Text] [Related]
7. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.
Bai J; Li X; Tong D; Shi W; Song H; Li Q
Tumour Biol; 2013 Apr; 34(2):805-9. PubMed ID: 23359271
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
[TBL] [Abstract][Full Text] [Related]
9. The relationship between polymorphisms in the promoter region of Tim-3 and unexplained recurrent spontaneous abortion in Han Chinese women.
Shen Y; Wang C; Hong D; Zeng B; Fang C; Yuan C; Fan L; Lv H; Zhu M
Reprod Biol Endocrinol; 2013 Nov; 11():104. PubMed ID: 24209883
[TBL] [Abstract][Full Text] [Related]
10. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
11. Relationship between TIM-3 gene polymorphisms and steroid-resistant primary nephrotic syndrome in children.
Lei J; Ma S
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):72-75. PubMed ID: 33287925
[TBL] [Abstract][Full Text] [Related]
12. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes.
Kamal AM; Wasfey EF; Elghamry WR; Sabry OM; Elghobary HA; Radwan SM
Clin Biochem; 2021 Oct; 96():13-18. PubMed ID: 34217699
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
15. Roles of genetic variants in the PI3K/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen.
Lin L; Zhang Z; Zhang W; Wang L; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13314-22. PubMed ID: 26722535
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.
Chen XL; Wang YM; Zhao F; Chen Z; Yang X; Sun C; Gao Y; Yang TG; Tian G; Chen YM; Zhu SL; Lin XB; Liu FB
J Gene Med; 2019 Sep; 21(9):e3114. PubMed ID: 31330573
[TBL] [Abstract][Full Text] [Related]
17. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
Huang B; Liu X; Sun C; Wang L; Yang L
Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
[TBL] [Abstract][Full Text] [Related]
18. T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Susceptibility to Invasive Breast Cancer.
Cheng S; Ju Y; Han F; Wang Y; Xu Y; Qu T; Lu Z
Ann Clin Lab Sci; 2017 Nov; 47(6):668-675. PubMed ID: 29263040
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
[TBL] [Abstract][Full Text] [Related]
20. The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.
Pei JP; Jiang LF; Ji XW; Xiao W; Deng XZ; Zhou ZX; Zhu DY; Ding WL; Zhang JH; Wang CJ; Jing K
Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1377-86. PubMed ID: 27230511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
